Expand2025 Hypertension Guideline Update Modestly Expands Stage 1 Treatment Eligibility, with Net Increases Concentrated Among Older and Female Patients
Among adults aged 40–79 with stage 1 hypertension, treatment eligibility rose modestly from 45.2% under the 2017 guideline to 47.0% under the 2025 guideline. Overall, 3.2% of patients would be treated differently under the new guideline (2.5% gained eligibility, 0.7% lost eligibility).



















